PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology data.
@article{Bergenholm2016PKPDMO, title={PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology data.}, author={L. Bergenholm and T. Collins and N. Evans and M. Chappell and J. Parkinson}, journal={Journal of pharmacological and toxicological methods}, year={2016}, volume={79}, pages={ 34-44 } }
INTRODUCTION
Pharmacokinetic-pharmacodynamic (PKPD) modelling can improve safety assessment, but few PKPD models describing drug-induced QRS and PR prolongations have been published. This investigation aims to develop and evaluate PKPD models for describing QRS and PR effects in routine safety studies.
METHODS
Exposure and telemetry data from safety pharmacology studies in conscious beagle dogs were acquired. Mixed effects baseline and PK-QRS/PR models were developed for the anti-arrhythmic… CONTINUE READING
Figures, Tables, and Topics from this paper
6 Citations
A pharmacological characterization of electrocardiogram PR and QRS intervals in conscious telemetered rats.
- Medicine
- Journal of pharmacological and toxicological methods
- 2020
Predicting QRS and PR interval prolongations in humans using nonclinical data
- Medicine
- British journal of pharmacology
- 2017
- 4
- PDF
Parameter Identifiability of Fundamental Pharmacodynamic Models
- Computer Science, Medicine
- Front. Physiol.
- 2016
- 26
- PDF
Semi‐mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities
- Medicine
- British journal of pharmacology
- 2020
Computational translation of drug effects from animal experiments to human ventricular myocytes
- Medicine
- Scientific Reports
- 2020
- 3
- PDF
References
SHOWING 1-10 OF 51 REFERENCES
Identifying the translational gap in the evaluation of drug-induced QTc interval prolongation.
- Medicine
- British journal of clinical pharmacology
- 2013
- 32
A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551.
- Medicine
- Journal of pharmacological and toxicological methods
- 2011
- 13
- Highly Influential
Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing.
- Medicine
- Journal of pharmacological and toxicological methods
- 2015
- 5
- Highly Influential
Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
- Medicine
- Journal of pharmacological and toxicological methods
- 2014
- 4
- Highly Influential
Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human.
- Medicine
- Journal of pharmacological and toxicological methods
- 2013
- 33
The role of concentration−effect relationships in the assessment of QTc interval prolongation
- Medicine
- 2015
- 14
The role of concentration−effect relationships in the assessment of QTc interval prolongation
- Medicine
- British journal of clinical pharmacology
- 2015
- 15
Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
- Medicine
- Journal of pharmacological and toxicological methods
- 2014
- 16
- Highly Influential
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
- Medicine
- The AAPS Journal
- 2008
- 116
- PDF
Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.
- Medicine
- Toxicology and applied pharmacology
- 2012
- 11